nephrology,nephtwitter,kidneydisease,diabetes,ozempic,semaglutide

Mashup Score: 1

FDA Approves Ozempic for Kidney Disease | Docwire News - 2 day(s) ago

Based on FLOW trial results, the FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.

Source: docwirenews.com

Categories: General Medicine News, Partners & KOLs

Tweet Tweets with this article
- Neph_Times
  
  ⚠️ The FDA has approved Ozempic for use in kidney disease. #nephrology #nephtwitter #kidneydisease #diabetes #ozempic #semaglutide https://t.co/PMVGkOxpbW https://t.co/d5qtJa1Bgl